Does BAMLANIVIMAB Cause Infusion site extravasation? 45 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 45 reports of Infusion site extravasation have been filed in association with BAMLANIVIMAB. This represents 0.9% of all adverse event reports for BAMLANIVIMAB.
45
Reports of Infusion site extravasation with BAMLANIVIMAB
0.9%
of all BAMLANIVIMAB reports
0
Deaths
3
Hospitalizations
How Dangerous Is Infusion site extravasation From BAMLANIVIMAB?
Of the 45 reports, 3 (6.7%) required hospitalization.
Is Infusion site extravasation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BAMLANIVIMAB. However, 45 reports have been filed with the FAERS database.
What Other Side Effects Does BAMLANIVIMAB Cause?
Dyspnoea (833)
Infusion related reaction (663)
Pyrexia (641)
Chills (453)
Oxygen saturation decreased (448)
Nausea (422)
Covid-19 (346)
Cough (342)
Covid-19 pneumonia (313)
Hypoxia (310)
What Other Drugs Cause Infusion site extravasation?
HUMAN IMMUNOGLOBULIN G (822)
INFLIXIMAB (435)
INFLIXIMAB-DYYB (328)
TREPROSTINIL (256)
VEDOLIZUMAB (199)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN (185)
REMDESIVIR (144)
FERRIC CARBOXYMALTOSE (118)
RITUXIMAB (82)
NATALIZUMAB (70)
Which BAMLANIVIMAB Alternatives Have Lower Infusion site extravasation Risk?
BAMLANIVIMAB vs BAMLANIVIMAB\ETESEVIMAB
BAMLANIVIMAB vs BARACLUDE
BAMLANIVIMAB vs BARICITINIB
BAMLANIVIMAB vs BARIUM
BAMLANIVIMAB vs BARNIDIPINE